ADL-5859

From WikiMD's Wellness Encyclopedia

Revision as of 21:18, 11 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

A selective agonist of the _-opioid receptor


ADL-5859
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number 870729-49-6
PubChem 11550036
DrugBank
ChemSpider 9724444
KEGG


ADL-5859 is a pharmacological compound that acts as a selective agonist of the _-opioid receptor. It has been investigated for its potential use in the treatment of pain and inflammation.

Mechanism of Action

ADL-5859 functions by selectively binding to and activating the _-opioid receptor, which is one of the four main types of opioid receptors in the body. The _-opioid receptor is involved in modulating pain perception, mood, and other physiological processes. Unlike the _-opioid receptor, which is the primary target of most opioid analgesics, the _-opioid receptor is associated with fewer side effects such as respiratory depression and addiction.

Pharmacological Effects

The activation of _-opioid receptors by ADL-5859 has been shown to produce analgesic effects in preclinical studies. This suggests that ADL-5859 could potentially be used as a pain reliever with a lower risk of addiction and other side effects compared to traditional opioids. Additionally, _-opioid receptor agonists like ADL-5859 may have antidepressant and anxiolytic effects, although these effects require further investigation.

Clinical Development

ADL-5859 has undergone various stages of clinical trials to evaluate its efficacy and safety in humans. These trials aim to determine the optimal dosing, potential therapeutic applications, and any adverse effects associated with the drug. The development of ADL-5859 is part of a broader effort to create new analgesics that provide effective pain relief without the drawbacks of current opioid medications.

Potential Applications

The primary application of ADL-5859 is in the management of pain, particularly in conditions where traditional opioids are either ineffective or pose significant risks. It may also be explored for use in treating mood disorders due to its potential effects on mood regulation.

Related pages

Gallery

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your life with W8MD's Budget GLP-1 injections from $49.99


W8MD weight loss doctors team
W8MD weight loss doctors team

W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:

NYC weight loss doctor appointmentsNYC weight loss doctor appointments

Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.

Linkedin_Shiny_Icon Facebook_Shiny_Icon YouTube_icon_(2011-2013) Google plus


Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.